Literature DB >> 31373146

Double diabetes: A distinct high-risk group?

Noppadol Kietsiriroje1,2, Sam Pearson1, Matthew Campbell3, Robert A S Ariëns1, Ramzi A Ajjan1.   

Abstract

The term double diabetes (DD) has been used to refer to individuals with type 1 diabetes (T1D) who are overweight, have a family history of type 2 diabetes and/or clinical features of insulin resistance. Several pieces of evidence indicate that individuals who display features of DD are at higher risk of developing future diabetes complications, independently of average glucose control, measured as glycated haemoglobin (HbA1c) concentration. Given the increased prevalence of individuals with features of DD, pragmatic criteria are urgently required to identify and stratify this group, which will help with subsequent implementation of more effective personalized interventions. In this review, we discuss the potential criteria for the clinical identification of individuals with DD, highlighting the strengths and weaknesses of each definition. We also cover potential mechanisms of DD and how these contribute to increased risk of diabetes complications. Special emphasis is placed on the role of estimated glucose disposal rate (eGDR) in the diagnosis of DD, which can be easily incorporated into clinical practice and is predictive of adverse clinical outcome. In addition to the identification of individuals with DD, eGDR has potential utility in monitoring response to different interventions. T1D is a more heterogeneous condition than initially envisaged, and those with features of DD represent a subgroup at higher risk of complications. Pragmatic criteria for the diagnosis of individuals with DD will help with risk stratification, allowing a more personalized and targeted management strategy to improve outcome and quality of life in this population.
© 2019 John Wiley & Sons Ltd.

Entities:  

Keywords:  double diabetes; estimated glucose disposal rate; metabolic syndrome; obesity; type 1 diabetes

Mesh:

Substances:

Year:  2019        PMID: 31373146     DOI: 10.1111/dom.13848

Source DB:  PubMed          Journal:  Diabetes Obes Metab        ISSN: 1462-8902            Impact factor:   6.577


  13 in total

1.  Glucose variability is associated with an adverse vascular profile but only in the presence of insulin resistance in individuals with type 1 diabetes: An observational study.

Authors:  Noppadol Kietsiriroje; Sam M Pearson; Lauren L O'Mahoney; Daniel J West; Robert As Ariëns; Ramzi A Ajjan; Matthew D Campbell
Journal:  Diab Vasc Dis Res       Date:  2022 May-Jun       Impact factor: 3.541

2.  A Holistic View of the Goto-Kakizaki Rat Immune System: Decreased Circulating Immune Markers in Non- Obese Type 2 Diabetes.

Authors:  Snehaa V Seal; Mathilde Henry; Clémentine Pajot; Cyrielle Holuka; Danielle Bailbé; Jamileh Movassat; Muriel Darnaudéry; Jonathan D Turner
Journal:  Front Immunol       Date:  2022-05-23       Impact factor: 8.786

3.  Prevalence of Nonalcoholic Fatty Liver Disease (NAFLD) in Patients With Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis.

Authors:  Marieke de Vries; Jan Westerink; Karin H A H Kaasjager; Harold W de Valk
Journal:  J Clin Endocrinol Metab       Date:  2020-12-01       Impact factor: 5.958

Review 4.  Nutrition and Obesity in the Pathogenesis of Youth-Onset Type 1 Diabetes and Its Complications.

Authors:  Christine A March; Dorothy J Becker; Ingrid M Libman
Journal:  Front Endocrinol (Lausanne)       Date:  2021-03-22       Impact factor: 5.555

5.  Estimated glucose disposal rate demographics and clinical characteristics of young adults with type 1 diabetes mellitus: A cross-sectional pilot study.

Authors:  Revathi Nishtala; Noppadol Kietsiriroje; Mohammad Karam; Ramzi A Ajjan; Sam Pearson
Journal:  Diab Vasc Dis Res       Date:  2020 May-Jun       Impact factor: 3.291

6.  The association between overweight/obesity and double diabetes in adults with type 1 diabetes; a cross-sectional study.

Authors:  Nathan Wp Cantley; Kathryn Lonnen; Ioannis Kyrou; Abd A Tahrani; Hassan Kahal
Journal:  BMC Endocr Disord       Date:  2021-09-16       Impact factor: 2.763

7.  Clinical and metabolic characteristics of children with hybrid diabetes mellitus (HD) compared to children with type 2 diabetes mellitus (T2DM): A preliminary comparative study.

Authors:  Vincenzo De Sanctis; Ashraf Soliman; Fawzia Alyafei; Nada Alaaraj; Shayma Ahmed; Ahmed Elawwa; Noor Hamed
Journal:  Acta Biomed       Date:  2021-11-03

8.  Estimated glucose disposal rate as a candidate biomarker for thrombotic biomarkers in T1D: a pooled analysis.

Authors:  L L O'Mahoney; N Kietsiriroje; S Pearson; D J West; M Holmes; R A Ajjan; M D Campbell
Journal:  J Endocrinol Invest       Date:  2021-03-17       Impact factor: 4.256

9.  Serum urate and cardiovascular events in the DCCT/EDIC study.

Authors:  Alicia J Jenkins; Barbara H Braffett; Arpita Basu; Ionut Bebu; Samuel Dagogo-Jack; Trevor J Orchard; Amisha Wallia; Maria F Lopes-Virella; W Timothy Garvey; John M Lachin; Timothy J Lyons
Journal:  Sci Rep       Date:  2021-07-09       Impact factor: 4.379

10.  Epidemiology, genetic landscape and classification of childhood diabetes mellitus in the State of Qatar.

Authors:  Basma Haris; Saras Saraswathi; Sara Al-Khawaga; Reem Hasnah; Amira Saeed; Shihab Mundekkadan; Noor Hamed; Houda Afyouni; Tasneem Abdel-Karim; Shayma Mohammed; Amel Khalifa; Maryam Al-Maadheed; Mahmoud Al-Zyoud; Ahmed Shamekh; Ahmed Elawwa; Fawziya Al-Khalaf; Sabri Boughorbel; Goran Petrovski; Khalid Hussain
Journal:  J Diabetes Investig       Date:  2021-07-04       Impact factor: 4.232

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.